title: C16 laminin peptide increases angiotropic extravascular migration of human melanoma cells in a shell-less chick chorioallantoic membrane assay.
abstract: BACKGROUND
  As distinct from intravascular dissemination, extravascular migratory metastasis (EVMM) has been described as a potential additional mechanism of melanoma spread in which tumour cells migrate along the external surfaces of vessels. Recent experimental studies strongly suggest a correlation of angiotropism of melanoma cells with EVMM. Angiotropic melanoma cells are linked to the endothelium by an amorphous matrix confirmed to contain laminin.
  
  
  OBJECTIVE
  To investigate whether laminin plays a role in this extravascular mechanism of tumour spread.
  
  
  METHODS
  We tested the effect of the C16 laminin peptide on melanoma spread in a shell-less chick chorioallantoic membrane model.
  
  
  RESULTS
  After 3 days, green fluorescent protein-expressing melanoma cells were observed spreading along or in the immediate proximity of vessels. The C16 laminin peptide significantly lengthened the distance of extravascular, angiotropic migration of melanoma cells. Histopathology confirmed the angiotropism of melanoma cells without intravasation, compatible with that observed with human angiotropic melanoma.
  
  
  CONCLUSIONS
  The results of this study suggest that the C16 laminin gamma1 chain peptide has angiotropic, extravascular migration-promoting activity on human melanoma cells, and might be a molecular target for preventing melanoma metastasis.
authors: Department of Pathology, University of Miami Miller School of Medicine-JMH, Miami, FL 33136, USA. clugassy@med.miami.edu
authors: C
authors: C
authors: Lugassy
authors: H K
authors: HK
authors: Kleinman
authors: S E
authors: SE
authors: Vernon
authors: D R
authors: DR
authors: Welch
authors: R L
authors: RL
authors: Barnhill
mesh_terms: D000818:Animals; D002465:Cell Movement / Q000187:drug effects; D002642:Chick Embryo; D049033:Chorioallantoic Membrane / Q000473:pathology; D006801:Humans; D007797:Laminin / Q000494:pharmacology*; D008546:Melanoma, Experimental / Q000473:pathology* / Q000556:secondary; D008833:Microcirculation / Q000473:pathology; D008954:Models, Biological; D009361:Neoplasm Invasiveness; D010446:Peptide Fragments / Q000494:pharmacology
chemical_list: D007797:Laminin; D010446:Peptide Fragments; C121346:laminin 1